CRISPR

CRISPR1-mespaa

ID

ZDB-CRISPR-161123-1

Name

CRISPR1-mespaa

Previous Names

None

Target

mespaa (1)

Sequence

5' - CCGAAGAGAACCGGACGT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
hsc11	mespaa

Expression

Gene expression in Wild Types + CRISPR1-mespaa

No data available

Phenotype

Phenotype resulting from CRISPR1-mespaa

No data available

Phenotype of all Fish created by or utilizing CRISPR1-mespaa

Phenotype	Fish	Conditions	Figures
heart primordium spw expression absent, abnormal	mespaa^hsc11/hsc11	standard conditions	Fig. S4 from Deshwar et al., 2016
left/right pattern formation decreased efficacy, abnormal	mespaa^hsc11/hsc11	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium right side lft2 expression mislocalised, abnormal	mespaa^hsc11/hsc11	standard conditions	Fig. 4 from Deshwar et al., 2016
left/right pattern formation decreased efficacy, abnormal	mespaa^hsc11/hsc11	standard conditions	Fig. S4 from Deshwar et al., 2016
determination of heart left/right asymmetry decreased efficacy, abnormal	mespaa^hsc11/hsc11	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium right side lft1 expression mislocalised, abnormal	mespaa^hsc11/hsc11	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium right side spw expression mislocalised, abnormal	mespaa^hsc11/hsc11	standard conditions	Fig. S4 from Deshwar et al., 2016
heart primordium lft1 expression absent, abnormal	mespaa^hsc11/hsc11 + MO1-mespab	standard conditions	Fig. 4 from Deshwar et al., 2016
left/right pattern formation decreased efficacy, abnormal	mespaa^hsc11/hsc11 + MO1-mespab	standard conditions	Fig. 4 from Deshwar et al., 2016
determination of heart left/right asymmetry decreased efficacy, abnormal	mespaa^hsc11/hsc11 + MO1-mespab	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium right side lft1 expression mislocalised, abnormal	mespaa^hsc11/hsc11 + MO1-mespab	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium right side lft2 expression mislocalised, abnormal	mespaa^hsc11/hsc11 + MO1-mespab	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium lft2 expression absent, abnormal	mespaa^hsc11/hsc11 + MO1-mespab	standard conditions	Fig. 4 from Deshwar et al., 2016
left/right pattern formation decreased efficacy, abnormal	mespaa^hsc11/hsc11 + MO1-mespba	standard conditions	Fig. 4 from Deshwar et al., 2016
determination of heart left/right asymmetry decreased efficacy, abnormal	mespaa^hsc11/hsc11 + MO1-mespba	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium right side lft1 expression mislocalised, abnormal	mespaa^hsc11/hsc11 + MO1-mespba	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium right side lft2 expression mislocalised, abnormal	mespaa^hsc11/hsc11 + MO1-mespba	standard conditions	Fig. 4 from Deshwar et al., 2016
determination of heart left/right asymmetry decreased efficacy, abnormal	mespaa^hsc11/hsc11 + MO3-mespbb	standard conditions	Fig. 4 from Deshwar et al., 2016
left/right pattern formation decreased efficacy, abnormal	mespaa^hsc11/hsc11 + MO3-mespbb	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium right side lft1 expression mislocalised, abnormal	mespaa^hsc11/hsc11 + MO3-mespbb	standard conditions	Fig. 4 from Deshwar et al., 2016
heart primordium right side lft2 expression mislocalised, abnormal	mespaa^hsc11/hsc11 + MO3-mespbb	standard conditions	Fig. 4 from Deshwar et al., 2016

Citations